Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) EBT Margin (2016 - 2026)

Champions Oncology has reported EBT Margin over the past 17 years, most recently at 1.43% for Q1 2026.

  • Quarterly results put EBT Margin at 1.43% for Q1 2026, down 2795.0% from a year ago — trailing twelve months through Jan 2026 was 4.14% (down 1506.0% YoY), and the annual figure for FY2025 was 8.12%, up 2269.0%.
  • EBT Margin for Q1 2026 was 1.43% at Champions Oncology, down from 1.7% in the prior quarter.
  • Over the last five years, EBT Margin for CSBR hit a ceiling of 26.52% in Q1 2025 and a floor of 20.96% in Q1 2024.
  • Median EBT Margin over the past 5 years was 2.2% (2022), compared with a mean of 4.41%.
  • Biggest five-year swings in EBT Margin: soared 4747bps in 2025 and later crashed -2795bps in 2026.
  • Champions Oncology's EBT Margin stood at 0.01% in 2022, then tumbled by -127001bps to 17.8% in 2023, then soared by 131bps to 5.48% in 2024, then plummeted by -69bps to 1.7% in 2025, then tumbled by -184bps to 1.43% in 2026.
  • The last three reported values for EBT Margin were 1.43% (Q1 2026), 1.7% (Q4 2025), and 3.23% (Q3 2025) per Business Quant data.